Therapy insight: hepatopulmonary syndrome and orthotopic liver transplantation

Hepatopulmonary syndrome (HPS)-a pulmonary complication observed in patients who have chronic liver disease and/or portal hypertension-is attributed to intrapulmonary vascular dilatation and induces severe hypoxemia. HPS is mainly detected when patients are included on the waiting list for orthotopic liver transplantation (OLT) and can be diagnosed by blood gas analysis, transthoracic contrast-enhanced echocardiography or body scan with Tc-99m-labeled macroaggregated albumin perfusion. When the partial pressure of arterial oxygen (PaO2) is >= 80 mmHg, it is unlikely that the patient has HPS. When the PaO2 is < 80 mmHg, imaging techniques should be used to confirm or exclude pulmonary vascular dilatation. When a diagnosis of HPS is confirmed, knowing the degree of hypoxemia is crucial for optimum patient management. Patients who have a PaO2 >= 50 mmHg but < 60 mmHg should be prioritized for OLT. This procedure is not indicated for patients with a PaO2 between 60 mmHe and 80 mmHg, although follow-up every 3 months is recommended to detect any deterioration of the PaO2. A PaO2 of < 50 mmHg might preclude OLT, because mortality and morbidity after OLT are greatly increased in these patients.